We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
30 hedge funds and large institutions have $55.9M invested in Sorrento Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
533% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 3
103% more capital invested
Capital invested by funds: $27.5M → $55.9M (+$28.3M)
100% more funds holding
Funds holding: 15 → 30 (+15)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
30
Holders Change
+15
Holders Change %
+100%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
5
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.75M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.8M |
| 3 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$1.11M |
| 4 |
B
Baird
Milwaukee,
Wisconsin
|
+$759K |
| 5 |
Jane Street
New York
|
+$734K |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$1.83M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.8M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$356K |
| 4 |
SC
Sophrosyne Capital
New York
|
-$316K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$245K |
